Cytokine Phenotypes After the Host's Response During Chronic Lung Inflammation

慢性肺部炎症期间宿主反应后的细胞因子表型

基本信息

批准号：
8387726
负责人：
Steven Lynn Kunkel
金额：
$ 35.69万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-12-01 至 2014-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8387726
关键词：
Animals Autoimmune Diseases Automobile Driving Cell physiology Cells Chronic Chronic Disease Chronic lung disease Clinical Clinical Management Collagen Communicable Diseases Connective Tissue Diseases Dendritic Cells Deterioration Disease Disease Progression Environment Etiology Evolution Experimental Models Fibroblasts Fibrosis Growth Hamman-Rich syndrome Immune Immune Cell Activation Immune response Infection Injury Interleukin-13 Interleukin-4 Interstitial Lung Diseases Investigation Label Laboratories Lead Lesion Lung Lung Inflammation Lung diseases Maintenance Modeling Mus Outcome Pathology Phenotype Predisposition Proteins Research Respiratory physiology Risk Structure of parenchyma of lung Testing Tissues Transforming Growth Factor beta Viral Virus Diseases cytokine design gammaherpesvirus interstitial pathogen research study response

项目摘要

Chronic interstitial lung disease is observed in a variety of disorders, including infectious diseases, autoimmune disorders of connective tissue, and disorders where the etiology is unknown, such as idiopathic pulmonary fibrosis. While the etiology and mechanism of progression of many of these lung disorders are not known, the exacerbated progression of the disease may be dictated by the host responding to a subsequent pathogen superimposed on the initial etiologic agent. This "second hit" triggers a dynamic interaction in the lung between the inciting agent, immune cells, and structural cells of the lung, culminating in fibroblast activation, proliferation and fibrosis. Understanding the mechanisms responsible for the exacerbation and progression of lung disease chronicity and fibrosis are the broad, long-term objectives of this application. We hypothesize that the host's response to a persistent etiologic agent may predispose lung tissue to an environment of reparative and immunoregulatory cytokines, placing the lungs at risk for a viral infection, which mechanistically contributes to disease chronicity by maintaining a unique cytokine phenotype, altering dendritic cell function, and driving fibroblast activation. We have designed experiments to test this hypothesis and determine if the progression and maintenance of chronic lung inflammation are infuenced by the cytokine phenotype and the host's response to a subsequent viral pathogen superimposed on the initial etiologic agent, constituting a "two hit" mechanism for disease progression. We will focus on mechanisms which lead to a minimally fibrotic lung lesion, induced by type 1 cytokines, versus a fibrotic response, induced by type 2 cytokines, and determine their impact on a subsequent challenging with murine gammaherpesvirus (MHV68). Our specific Aims include: 1) To assess the mechanism(s) whereby MHV68 infection alone or superimposed on a polarized cytokine phenotype alters the host response and subsequent lung pathology in experimental models of chronic lung inflammation; 2) To determine the mechanistic contribution of an MHV68-derived gene product on the evolving chronic lung pathology associated with a type 1 or type 2 cytokine tissue phenotype; and 3) To assess the mechanistic contribution of dendritic cell subsets during MHV68 infection to the chronicity and fibrosis of the lung response in animals with developing type 1 or type 2 cytokine phenotypes.

在多种疾病中观察到慢性间质性肺疾病，包括传染病，结缔组织的自身免疫性疾病和病因尚不清楚的疾病，例如特发性肺纤维化。尽管许多肺部疾病的病因和进展机制不是已知，疾病的恶化进展可能取决于宿主对随后的反应病原体叠加在初始病因学剂上。 “第二击”触发了动态交互肺部的肺部，免疫细胞和肺的结构细胞之间，达到成纤维细胞激活，增殖和纤维化。了解导致加重和的机制肺部疾病慢性和纤维化的进展是该应用的广泛，长期目标。我们假设宿主对持续性病因的反应可能使肺组织倾向于修复和免疫调节细胞因子的环境，使肺有病毒感染的风险，机械上通过维持独特的细胞因子表型来促进疾病的慢性树突状细胞功能和驱动成纤维细胞激活。我们设计了实验来检验此假设并确定慢性肺炎症的进展和维持是否受到细胞因子的影响表型和宿主对随后的病毒病原体的反应叠加在初始病因学剂上，构成疾病进展的“两个命中”机制。我们将专注于导致的机制通过1型细胞因子诱导的最小纤维化肺病变，而纤维化反应，由2型诱导细胞因子，并确定它们对随后对鼠伽马犬病毒（MHV68）的挑战性挑战的影响。我们的具体目的包括：1）评估单独感染或叠加的MHV68的机制在极化的细胞因子表型上，改变了实验中宿主反应和随后的肺病理慢性肺部炎症的模型； 2）确定MHV68衍生基因的机械贡献与1型或2型细胞因子组织表型相关的慢性肺病理学的产物； 3）评估MHV68感染期间树突状细胞子集对慢性的机理贡献和肺反应的纤维化在具有开发1型或2型细胞因子表型的动物中。

项目成果

期刊论文数量（9）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.

DOI：
10.1016/j.intimp.2011.07.004
发表时间：
2011-11
期刊：
International immunopharmacology
影响因子：
5.6
作者：
G. Tarrasón;M. Aulí;Sanam Mustafa;V. Dolgachev;M. T. Domenech;N. Prats;María Domínguez;Rosa López;Nuria Aguilar;M. Calbet;M. Pont;G. Milligan;S. Kunkel;N. Godessart
通讯作者：
G. Tarrasón;M. Aulí;Sanam Mustafa;V. Dolgachev;M. T. Domenech;N. Prats;María Domínguez;Rosa López;Nuria Aguilar;M. Calbet;M. Pont;G. Milligan;S. Kunkel;N. Godessart

Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.

DOI：
10.4049/jimmunol.1302766
发表时间：
2014-04-15
期刊：
Journal of immunology (Baltimore, Md. : 1950)
影响因子：
0
作者：
Shibata T;Habiel DM;Coelho AL;Kunkel SL;Lukacs NW;Hogaboam CM
通讯作者：
Hogaboam CM

Viral disruption of olfactory progenitors is exacerbated in allergic mice.

在过敏小鼠中，病毒对嗅觉祖细胞的破坏更加严重。

DOI：
10.1016/j.intimp.2014.06.034
发表时间：
2014
期刊：
International immunopharmacology
影响因子：
5.6
作者：
Ueha,R;Mukherjee,S;Ueha,S;deAlmeidaNagata,DE;Sakamoto,T;Kondo,K;Yamasoba,T;Lukacs,NW;Kunkel,SL
通讯作者：
Kunkel,SL

Jagged-1 Reduces Th2 Inflammation and Memory Cell Expansion in Allergic Airway Disease.

DOI：
10.4049/immunohorizons.2300001
发表时间：
2023-02-01
期刊：
ImmunoHorizons
影响因子：
0
作者：
Kimura S;Dupee Z;Lima F;Allen R;Kazmi S;Diodati N;Lukacs NW;Kunkel SL;Schaller M
通讯作者：
Schaller M

Monocytes to functional dendritic cells is often a bridge too far for cancer therapy.